Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
posted on 2020-12-24, 11:04authored byAdis journals on behalf of, Akshay B. Jain, Steve Kanters, Reena Khurana, Jagoda Kissock, Naomi Severin, Sara G. Stafford
Article
full text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).